PerformanceRead the research
SS-31
10 mg / 50 mg
Mitochondrial-targeted tetrapeptide (Elamipretide), investigated in cardiac, neurological, and age-related mitochondrial research.
$65
For laboratory and research use only. Not for human or animal consumption.
Secure card checkout — instant order confirmation.
Specifications
| Format | Lyophilized powder |
|---|---|
| Amount per vial | 10 mg / 50 mg |
| Presentation | Single-use sealed vial |
| Storage | Store lyophilized vial refrigerated or frozen; once reconstituted, keep refrigerated (2–8°C). |
| Purity | Third-party tested to 99%+. |
| Intended use | Laboratory and research use only. |
Areas of Research Interest
- Cardiovascular research, Ischemia-reperfusion injury, heart failure, and cardiac fibrosis have been extensively studied in animal models and human trials
- Mitochondrial myopathies, Primary and secondary mitochondrial disease models, including muscle biopsy studies in human patients
- Age-related sarcopenia, Aged rodent models have demonstrated improvements in muscle function and fatigue resistance with SS-31 administration
- Neurodegenerative research, Parkinson's, Alzheimer's, and optic neuropathy models have been examined for mitochondrial-protective effects
- Renal protection, Acute kidney injury and ischemic nephropathy preclinical models
